Abstract
Protein folding in the cell is a complex process with a fine balance between productive and non-productive folding. To modulate, either up-regulating or down-regulating, the level of one specific protein with multiple approaches is possible, including the modulation of catalysed protein folding, the use of chemical and pharmacological chaperones, alteration of natural protein-protein interactions, the regulation of degradative pathways and manipulation of natural control mechanisms, such as the heat shock response and the unfolded protein response. Errors in proteostasis are linked to a wide range of disease states and many examples exist of the successful manipulation of proteostasis for the partial or complete elimination of the disease phenotype, including for many amyloid based diseases such as Parkinsons and Alzheimers as as well as for loss-of-function diseases such as Fabrys and Gauchers diseases. This review takes an overview of the different approaches that can be used to alter proteostasis with an emphasis on peptidomimetic inhibitors and activators of protein folding. It covers the modulators available, their mechanisms of action and potential limitations, including the problems of specificity in altering proteostasis.
Keywords: Proteostasis, protein folding, peptidomimetic, pharmacological chaperone, chemical chaperone, molecular chaperone, degradation
Current Pharmaceutical Design
Title: Modulating Proteostasis: Peptidomimetic Inhibitors and Activators of Protein Folding
Volume: 15 Issue: 21
Author(s): Feras Hatahet and Lloyd W. Ruddock
Affiliation:
Keywords: Proteostasis, protein folding, peptidomimetic, pharmacological chaperone, chemical chaperone, molecular chaperone, degradation
Abstract: Protein folding in the cell is a complex process with a fine balance between productive and non-productive folding. To modulate, either up-regulating or down-regulating, the level of one specific protein with multiple approaches is possible, including the modulation of catalysed protein folding, the use of chemical and pharmacological chaperones, alteration of natural protein-protein interactions, the regulation of degradative pathways and manipulation of natural control mechanisms, such as the heat shock response and the unfolded protein response. Errors in proteostasis are linked to a wide range of disease states and many examples exist of the successful manipulation of proteostasis for the partial or complete elimination of the disease phenotype, including for many amyloid based diseases such as Parkinsons and Alzheimers as as well as for loss-of-function diseases such as Fabrys and Gauchers diseases. This review takes an overview of the different approaches that can be used to alter proteostasis with an emphasis on peptidomimetic inhibitors and activators of protein folding. It covers the modulators available, their mechanisms of action and potential limitations, including the problems of specificity in altering proteostasis.
Export Options
About this article
Cite this article as:
Hatahet Feras and Ruddock W. Lloyd, Modulating Proteostasis: Peptidomimetic Inhibitors and Activators of Protein Folding, Current Pharmaceutical Design 2009; 15 (21) . https://dx.doi.org/10.2174/138161209788682343
DOI https://dx.doi.org/10.2174/138161209788682343 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Physiology and Pharmacology of the Vanilloid Receptor
Current Neuropharmacology O-Arylation of Iodophenols with 2-Fluorobenzaldehyde Under Microwave Conditions
Letters in Drug Design & Discovery Expression of Opioid Receptors During Peripheral Inflammation
Current Topics in Medicinal Chemistry A Critical Analysis of New Molecular Targets and Strategies for Drug Developments in Alzheimers Disease
Current Drug Targets Psychological Factors Associated with Response to Treatment in Rheumatoid Arthritis
Current Pharmaceutical Design Cognitive Behavioral Therapy Online for Adult Depression: A 10 Year Systematic Literature Review
Current Psychiatry Research and Reviews Iodine Impregnated Nano Neutral Alumina as an Efficient Catalyst for One Pot Green Synthesis of Curcumin Analogues by Microwave Irradiation
Letters in Organic Chemistry Applications of Umbilical Cord Derived Mesenchymal Stem Cells in Autoimmune and Immunological Disorders: From Literature to Clinical Practice
Current Stem Cell Research & Therapy The Role for Oxidative Stress in Aberrant DNA Methylation in Alzheimer’s Disease
Current Alzheimer Research Treating Rapid Cycling Bipolar Disorder with Novel Medications
Current Psychiatry Reviews Downstream Processing for Production of Value Added Products from Coconut
Current Biochemical Engineering (Discontinued) Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives
Current Cancer Drug Targets Role of Neurotrophic Factors in Parkinson's Disease
Current Pharmaceutical Design Heme Oxygenase-1 against Vascular Insufficiency: Roles of Atherosclerotic Disorders
Current Pharmaceutical Design Reconceptualizing Adult Neurogenesis: Role for Sphingosine-1-Phosphate and Fibroblast Growth Factor-1 in Co-Ordinating Astrocyte-Neuronal Precursor Interactions
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue : What is Language? Different Viewpoints)
Neuroscience and Biomedical Engineering (Discontinued) Pharmacological Activity of Natural Non-glycosylated Triterpenes
Mini-Reviews in Organic Chemistry Recent Trends and Future Prospects in Computational GPCR Drug Discovery: From Virtual Screening to Polypharmacology
Current Topics in Medicinal Chemistry Mass Spectrometry-Based Approaches Toward Absolute Quantitative Proteomics
Current Genomics Long-acting Injectable vs. Oral Antipsychotics: Adherence, Persistence and Switching over three Years of Real-life Analysis
Current Reviews in Clinical and Experimental Pharmacology